---
document_datetime: 2023-12-18 16:03:16
document_pages: 14
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/feraccru-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf
document_name: feraccru-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 7.6168781
conversion_datetime: 2025-12-22 11:20:16.799269
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Feraccru

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                                                                                                                  | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| IB/0046/G            | This was an application for a group of variations. B.II.f.1.e - Stability of FP - Change to an approved stability protocol B.II.f.1.b.1 - Stability of FP - Extension of the shelf life of the finished product - As packaged for sale | 15/12/2023                          |                                             | SmPC                             |           |

1 Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions are issued for all other procedures.

2 A Commission decision (CD) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex II, labelling, package leaflet). The CD is issued within two months of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation (EU) No. 712/2012, or within one year for other procedures.

3 SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet).

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

|                     | (supported by real time data)                                                                                                                                                                       |            |            |                        |                                   |
|---------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|-----------------------------------|
| PSUSA/10476 /202302 | Periodic Safety Update EU Single assessment - ferric maltol                                                                                                                                         | 28/09/2023 | n/a        |                        | PRAC Recommendation - maintenance |
| IB/0044             | B.II.f.1.b.1 - Stability of FP - Extension of the shelf life of the finished product - As packaged for sale (supported by real time data)                                                           | 08/12/2022 |            | SmPC                   |                                   |
| PSUSA/10476 /202202 | Periodic Safety Update EU Single assessment - ferric maltol                                                                                                                                         | 29/09/2022 | n/a        |                        | PRAC Recommendation - maintenance |
| PSUSA/10476 /202108 | Periodic Safety Update EU Single assessment - ferric maltol                                                                                                                                         | 10/03/2022 | n/a        |                        | PRAC Recommendation - maintenance |
| IB/0042             | B.II.e.5.a.2 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change outside the range of the currently approved pack sizes | 09/02/2022 | 13/06/2022 | SmPC, Labelling and PL |                                   |
| IB/0041             | B.II.e.5.a.2 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change outside the range of the currently approved pack sizes | 09/02/2022 | 13/06/2022 | SmPC, Labelling and PL |                                   |
| IA/0040             | B.II.e.4.a - Change in shape or dimensions of the container or closure (immediate packaging) - Non- sterile medicinal products                                                                      | 13/12/2021 | n/a        |                        |                                   |
| IA/0039             | A.7 - Administrative change - Deletion of manufacturing sites                                                                                                                                       | 02/12/2021 | n/a        |                        |                                   |

<div style=\"page-break-after: always\"></div>

| PSUSA/10476 /202102   | Periodic Safety Update EU Single assessment - ferric maltol                                                                                                                                                                                                                                                                                                                                              | 30/09/2021   | n/a        |                        | PRAC Recommendation - maintenance   |
|-----------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|------------------------|-------------------------------------|
| IA/0037/G             | This was an application for a group of variations. B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place A.7 - Administrative change - Deletion of manufacturing sites B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure | 13/09/2021   | n/a        |                        |                                     |
| IB/0036               | B.II.e.5.a.2 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change outside the range of the currently approved pack sizes                                                                                                                                                                                                      | 06/08/2021   | 13/06/2022 | SmPC, Labelling and PL |                                     |
| IB/0035/G             | This was an application for a group of variations. C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure B.II.f.1.b.2 - Stability of FP - Extension of the shelf life of the finished product - After first opening (supported by real time data)  | 02/06/2021   | 13/06/2022 | SmPC, Annex II and PL  |                                     |

<div style=\"page-break-after: always\"></div>

|                     | B.III.1.b.4 - Submission of a new/updated or deletion of Ph. Eur. TSE Certificate of Suitability - Deletion of certificates (in case multiple certificates exist per material) B.II.a.3.b.6 - Changes in the composition (excipients) of the finished product - Other excipients - Replacement of a single excipient with a comparable excipient with the same functional characteristics and at a similar level   |            |            |                                  |                                                                                                                                                                                                                                 |
|---------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IB/0032/G           | This was an application for a group of variations. B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place A.7 - Administrative change - Deletion of manufacturing sites                                                                                                                        | 15/04/2021 | 13/06/2022 | Annex II and PL                  |                                                                                                                                                                                                                                 |
| PSUSA/10476 /202008 | Periodic Safety Update EU Single assessment - ferric maltol                                                                                                                                                                                                                                                                                                                                                        | 11/03/2021 | n/a        |                                  | PRAC Recommendation - maintenance                                                                                                                                                                                               |
| IAIN/0031           | B.II.a.1.a - Change or addition of imprints, bossing or other markings including replacement, or addition of inks used for product marking - Changes in imprints, bossing or other markings                                                                                                                                                                                                                        | 22/01/2021 | 13/06/2022 | SmPC and PL                      |                                                                                                                                                                                                                                 |
| R/0027              | Renewal of the marketing authorisation.                                                                                                                                                                                                                                                                                                                                                                            | 17/09/2020 | 25/11/2020 | SmPC, Annex II, Labelling and PL | Based on the review of data on quality, safety and efficacy, the CHMP considered that the benefit-risk balance of Feraccru in the approved indication remains favourable and therefore recommended the renewal of the marketing |

<div style=\"page-break-after: always\"></div>

|                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |            |            |    | authorisation with unlimited validity.   |
|---------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----|------------------------------------------|
| IA/0029/G           | This was an application for a group of variations. B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer B.III.1.a.4 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Deletion of certificates (in case multiple certificates exist per material) B.III.1.a.4 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Deletion of certificates | 20/11/2020 | n/a        |    |                                          |
| PSUSA/10476 /202002 | Periodic Safety Update EU Single assessment - ferric maltol                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | 01/10/2020 | n/a        |    | PRAC Recommendation - maintenance        |
| N/0028              | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | 01/09/2020 | 25/11/2020 | PL |                                          |

<div style=\"page-break-after: always\"></div>

| PSUSA/10476 /201908   | Periodic Safety Update EU Single assessment - ferric maltol                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             | 12/03/2020   | n/a        |                     | PRAC Recommendation - maintenance                                                                                                          |
|-----------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|---------------------|--------------------------------------------------------------------------------------------------------------------------------------------|
| IA/0025/G             | This was an application for a group of variations. B.I.b.1.d - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Deletion of a non- significant specification parameter (e.g. deletion of an obsolete parameter) B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.II.c.1.c - Change in the specification parameters and/or limits of an excipient - Deletion of a non- significant specification parameter (e.g. deletion of | 17/12/2019   | n/a        |                     |                                                                                                                                            |
| II/0022               | C.I.4 - Change(s) in the SPC, Labelling or PL due to new quality, preclinical, clinical or pharmacovigilance data                                                                                                                                                                                                                                                                                                                                                                                                                                                       | 14/11/2019   | 16/12/2019 | SmPC                |                                                                                                                                            |
| PSUSA/10476 /201902   | Periodic Safety Update EU Single assessment - ferric maltol                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             | 19/09/2019   | 22/11/2019 | SmPC and PL         | Refer to Scientific conclusions and grounds recommending the variation to terms of the Marketing Authorisation(s)' for PSUSA/10476/201902. |
| PSUSA/10476 /201808   | Periodic Safety Update EU Single assessment - ferric maltol                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             | 14/03/2019   | n/a        |                     | PRAC Recommendation - maintenance                                                                                                          |
| T/0020                | Transfer of Marketing Authorisation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | 11/12/2018   | 31/01/2019 | SmPC, Labelling and |                                                                                                                                            |

<div style=\"page-break-after: always\"></div>

|           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |            |            | PL                         |               |
|-----------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------|---------------|
| IB/0017/G | This was an application for a group of variations. B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site B.II.b.1.b - Replacement or addition of a manufacturing site for the FP - Primary packaging site B.II.b.1.e - Replacement or addition of a manufacturing site for the FP - Site where any manufacturing operation(s) take place, except batch- release, batch control, primary and secondary packaging, for non-sterile medicinal products B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place B.II.b.2.c.2 - Change to importer, batch release arrangements and quality control testing of the FP - Including batch control/testing B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test | 23/10/2018 | 31/01/2019 | Annex II, Labelling and PL | procedure     |
| IA/0018/G | This was an application for a group of variations. Submission of a new/updated or                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | 04/10/2018 | n/a        |                            | B.III.1.b.2 - |

<div style=\"page-break-after: always\"></div>

|                     | deletion of Ph. Eur. TSE Certificate of Suitability - New certificate for a starting material/reagent/intermediate/or excipient from a new or an already approved manufacturer B.III.1.b.2 - Submission of a new/updated or deletion of Ph. Eur. TSE Certificate of Suitability - New certificate for a starting material/reagent/intermediate/or excipient from a new or an already approved manufacturer B.III.1.b.2 - Submission of a new/updated or deletion of Ph. Eur. TSE Certificate of Suitability - New certificate for a starting material/reagent/intermediate/or excipient from a new or an already approved manufacturer B.III.1.b.3 - Submission of a new/updated or deletion of Ph. Eur. TSE Certificate of Suitability - Updated certificate from an already approved manufacturer B.III.1.b.4 - Submission of a new/updated or deletion of Ph. Eur. TSE Certificate of Suitability - Deletion of certificates (in case multiple certificates   |            |     |                                   |
|---------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|-----------------------------------|
| PSUSA/10476 /201802 | Periodic Safety Update EU Single assessment - ferric maltol                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | 06/09/2018 | n/a | PRAC Recommendation - maintenance |
| IA/0016/G           | This was an application for a group of variations. B.II.b.5.c - Change to in-process tests or limits applied during the manufacture of the finished product - Deletion of a non-significant in-process test                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | 26/07/2018 | n/a |                                   |

<div style=\"page-break-after: always\"></div>

|                     | B.III.1.b.2 - Submission of a new/updated or deletion of Ph. Eur. TSE Certificate of Suitability - New certificate for a starting material/reagent/intermediate/or excipient from a new or an already approved manufacturer                                                                                                                                                                                                                                                                                                                                                                                                |            |            |             |                                                                           |
|---------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-------------|---------------------------------------------------------------------------|
| IB/0015             | B.II.f.1.b.1 - Stability of FP - Extension of the shelf life of the finished product - As packaged for sale (supported by real time data)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | 15/06/2018 | 31/01/2019 | SmPC        |                                                                           |
| II/0010             | Extension of indication to widen the indication for Feraccru, from the treatment 'in adults with Iron deficiency anaemia in patients with IBD' to the treatment of 'adults with Iron deficiency'. As a consequence, sections 4.1, 4.8, 5.1 and 5.2 of the SmPC are updated. The Package Leaflet and RMP (v.8) have been updated accordingly. In addition, the Marketing authorisation holder (MAH) took the opportunity to update the list of local representatives in the Package Leaflet. C.I.6.a - Change(s) to therapeutic indication(s) - Addition of a new therapeutic indication or modification of an approved one | 22/02/2018 | 23/03/2018 | SmPC and PL | Please refer to the published Assessment Report Feraccru H-2733-II-10-AR. |
| PSUSA/10476 /201708 | Periodic Safety Update EU Single assessment - ferric maltol                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | 08/03/2018 | n/a        |             | PRAC Recommendation - maintenance                                         |
| IAIN/0013/G         | This was an application for a group of variations. A.7 - Administrative change - Deletion of                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | 14/12/2017 | n/a        |             |                                                                           |

<div style=\"page-break-after: always\"></div>

|           | manufacturing sites B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |            |     |               |
|-----------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|---------------|
| IB/0012/G | This was an application for a group of variations. B.I.a.1.z - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Other variation B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS B.I.a.3.d - Change in batch size (including batch size ranges) of AS or intermediate - More than 10-fold increase compared to the originally approved batch size B.I.a.4.z - Change to in-process tests or limits applied during the manufacture of the AS - Other variation B.I.b.1.z - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Other variation B.I.c.1.a - Change in immediate packaging of the AS and/or quantitative composition | 14/12/2017 | n/a | - Qualitative |
| IB/0009/G | This was an application for a group of variations. B.I.a.1.f - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Changes to quality control testing arrangements for                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | 02/10/2017 | n/a |               |

<div style=\"page-break-after: always\"></div>

<!-- image -->

|                     | the AS -replacement or addition of a site where batch control/testing takes place B.I.a.1.f - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Changes to quality control testing arrangements for the AS -replacement or addition of a site where batch control/testing takes place B.I.a.1.z - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Other variation B.I.a.1.z - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Other variation B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS B.I.a.3.d - Change in batch size (including batch size ranges) of AS or intermediate - More than 10-fold increase compared to the originally approved batch size B.I.b.1.z - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Other variation B.I.c.1.a - Change in immediate packaging of the AS - Qualitative and/or quantitative composition B.I.a.4.z - Change to in-process tests or limits   |            |     |                                   |
|---------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|-----------------------------------|
| PSUSA/10476 /201702 | Periodic Safety Update EU Single assessment - ferric maltol                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | 28/09/2017 | n/a | PRAC Recommendation - maintenance |

<div style=\"page-break-after: always\"></div>

| N/0008              | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                           | 29/06/2017   | 23/03/2018   | PL   |                                   |
|---------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|------|-----------------------------------|
| PSUSA/10476 /201608 | Periodic Safety Update EU Single assessment - ferric maltol                                                                                                                                                                                                                                                                                                                                                                                                                | 09/03/2017   | n/a          |      | PRAC Recommendation - maintenance |
| IA/0006/G           | This was an application for a group of variations. B.I.b.1.d - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Deletion of a non- significant specification parameter (e.g. deletion of an obsolete parameter) B.II.d.1.d - Change in the specification parameters and/or limits of the finished product - Deletion of a non-significant specification parameter                                                   | 06/02/2017   | n/a          |      |                                   |
| IA/0005/G           | This was an application for a group of variations. B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS B.I.a.3.a - Change in batch size (including batch size ranges) of AS or intermediate - Up to 10-fold increase compared to the originally approved batch size B.I.a.4.c - Change to in-process tests or limits applied during the manufacture of the AS - Deletion of a non-significant in-process test | 05/01/2017   | n/a          |      |                                   |

<div style=\"page-break-after: always\"></div>

|           | the finished or intermediate product - Minor change in the manufacturing process                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |            |            |      |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|-----------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| II/0002/G | This was an application for a group of variations. Submission of two final study reports for in vitro studies conducted as part of post-authorisation measures MEA 001 and MEA 002: - One drug-drug interaction study to investigate drug interactions with Feraccru - One drug-drug interaction study to identify UGT isoenzyme(s) that are responsible for metabolism of ferric maltol. Sections 4.5 and 5.2 of the SmPC and the RMP have been updated to reflect the completion and results of the studies. The variation leads to amendments to the Summary of Product Characteristics and to the Risk Management Plan. C.I.13 - Other variations not specifically covered elsewhere in this Annex which involve the submission of studies to the competent authority C.I.13 - Other variations not specifically covered elsewhere in this Annex which involve the submission | 15/12/2016 | 16/05/2017 | SmPC | With the present variation the MAH has submitted two in vitro studies, one to investigate the effect of Feraccru on the permeability of drugs known to interact with ferrous products (Study CYP0747 R3), and a second study (XenoGesis Study no. 2015_06_23, 2015) conducted to determine the UGT isoenzyme(s) responsible for the glucuronidation of the maltol component of ST10. The product information has been amended to reflect that maltol is glucuronised through UGT1A6 and by sulphation. It is not known if medical products that inhibit UGT enzymes have the potential to increase maltol concentration, but the possibility of an interaction of other drugs that inhibit UGT enzymes cannot be ruled out. |
| IB/0003   | B.II.f.1.b.1 - Stability of FP - Extension of the shelf life of the finished product - As packaged for sale (supported by real time data)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         | 06/09/2016 | 16/05/2017 | SmPC |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |

<div style=\"page-break-after: always\"></div>

| IAIN/0001   | A.1 - Administrative change - Change in the name and/or address of the MAH   | 11/05/2016   | 16/05/2017   | SmPC, Labelling and PL   |
|-------------|------------------------------------------------------------------------------|--------------|--------------|--------------------------|